Target intelligence / Profile preview

Multiple neurotransmitter systems

Molecular classification
Other (refers to a group of molecular families rather than a single molecule or protein), Includes G protein-coupled receptors, Ion channels, Enzymes, Transporters (as these are the types of proteins involved in neurotransmitter signaling)[2][4][5]
01

Overview

"Multiple neurotransmitter systems" is not the name of a single molecule or receptor but refers collectively to several distinct chemical signaling pathways in the nervous system. Each "system" is defined by its primary signaling molecule—such as acetylcholine for cholinergic neurons; dopamine for dopaminergic neurons; serotonin for serotonergic neurons; glutamate and GABA for glutamatergic and GABAergic neurons respectively—and includes all relevant synthetic enzymes, transporters, vesicular packaging proteins, release mechanisms at synapses, postsynaptic receptors (which may be ion channels or G protein-coupled receptors), and reuptake/degradation machinery[2][4][5]. These various transmitter systems regulate nearly every aspect of brain function including movement control (dopamine), mood regulation (serotonin), learning/memory (acetylcholine/glutamate), inhibition/excitation balance (GABA/glutamate), among others[1][3]. Dysregulation across one or more transmitter systems underlies many neurological and psychiatric diseases. However, "multiple neurotransmitter systems" does not refer to any one therapeutic target but rather an entire class comprising many different molecular entities—each with its own structure-function relationships and pharmacology. **Note:** The entry "Multiple neurotransmitter systems" is too broad/vague for structured data about an individual drug target. It should be replaced by specific names such as "Dopamine D2 receptor," "Serotonin transporter," etc.[2]

Other names
Multiple neurotransmitter systemsNeurotransmitter systemsNeurotransmitters (when used in a broad/systemic sense)
02

Biological functions

Signal transductionRegulation of neuronal activityModulation of synaptic transmissionControl of physiological processes such as mood, movement, cognition, and autonomic functions[1][3][9]
03

Disease associations

Neurodegenerative diseasePsychiatric disorders (e.g., depression, schizophrenia)Neurological disorders (e.g., epilepsy)Other central nervous system diseases[2]

Beyond the preview

Go deeper on Multiple neurotransmitter systems.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multiple neurotransmitter systems.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call